More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...

One of PanCAN’s key strategies to accelerate progress for patients with pancreatic cancer is to increase the federal research funding available to researchers around the country. Since 1999, we and ...

Gear, apparel, accessories and more to show off your purple pride.

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit outlines the latest advances in pancreatic cancer and offers ...

Together, we can improve pancreatic cancer outcomes. PanCAN supports our patient, caregiver and healthcare professional communities by providing free information and resources. Our services are backed ...

PanCAN’s Precision Promise Clinical Trial Consortium sites were selected through a competitive, peer-review process and include premier cancer treatment institutions across the country.

PanCAN and our national grassroots community of advocates led the charge to create the first-ever Pancreatic Cancer Research Program (PCARP) at the Department of Defense (DoD) in 2019. That year, ...

Today the American Cancer Society called out the need for more progress on pancreatic cancer, citing it as the third-leading cause of cancer-related death in the U.S. Their annual report also includes ...

Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and New Treatments for Patients LOS ANGELES, Calif. – (January 16, 2025) – After ...